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Most contributors were careful to cite foundational 
studies that form the underpinning of scientific investiga- 
tion in their area. Thus the references appropriately contain 
many citations from the 1960s or earlier. Other citations 
are as recent as 1993, indicating that the volume is accept- 
ably current when judged by textbook standards. 
In summary, the book occupies a rather narrow niche 
and is likely to be appreciated most by the basic scientists 
carrying on cell-based research who, like the editor, have 
recognized the same inadequacies in their texts on medical 
physiology and cell biology. The $99 price may dissuade 
people from purchasing the book for personal use if it is 
not likely to be a first-line reference. The book should be 
obtained by libraries of institutions where basic science 
research is performed. 
Larry W. Kraiss, MD 
University of Utah Medical School 
Salt Lake City, Utah 
The vascular smooth musde cell: Molecular and 
biological responses to the extracellular matrix 
Stephen M. Schwartz and Robert P. Mecham, San 
Diego, 1996, Academic Press, 410 pages, $95. 
This year is considered the twentieth anniversary of the 
smooth muscle cell as dated from the advent of the smooth 
muscle cell culture. Little information was initially forth- 
coming in the area of smooth muscle cell culture because it
was quickly discovered that cultured smooth muscle cells 
phenotypically modulate and lose their contractile appear- 
ance and function. In the past 20 years, however, there has 
been tremendous focus on understanding the structure 
and function of the smooth muscle cell because there is a 
general belief that a greater proportion of vascular disease 
is dependent on smooth muscle than endothelial cell func- 
tion. A comprehensive r view of current knowledge of the 
structure and function of the smooth muscle cell as it 
relates to vascular disease isthe focus of The vascular smooth 
muscle cell: Molecular and biological responses tothe extracel- 
lular matrix. 
This book consists of focused, in-depth reviews that 
provide both the clinical and basic science researcher with 
current information regarding vascular smooth muscle cell 
pathophysiology, written by authorities in the field of 
smooth muscle and vascular biology. The chapters are well 
integrated, with each chapter often referring the reader to 
other chapters of the book for either a better understand- 
ing or another point of view. In addition to the longer 
review-type chapters, there are four "overviews" ("Devel- 
opment of the smooth muscle cell," "Molecular identity of 
smooth muscle cells," "Molecular controls of smooth mus- 
cle hypertrophy and hyperplasia," and "Smooth muscle cell 
function from the clinical perspective"). These overviews 
provide both insight into the importance of the subsequent 
chapters as well as suggested readings. The chapters that 
follow describe the most current understanding of smooth 
muscle cell function and structure as related to vascular 
disease. These reviews are not intended to provide basic 
understanding of processes uch as smooth muscle con- 
traction, but rather up-to-date information on the place of 
the smooth muscle cell in vascular biology and pathology. 
The opening chapter, an overview ritten by Gordon 
and Julie Campbell, describes phenotypic modulation of 
smooth muscle cells and its importance to neointimal for- 
marion. This topic is further addressed in two subsequent 
chapters ("Vascular smooth muscle-specific gene expres- 
sion" and "Smooth muscle cell and fibroblast biological 
features: similarities and differences"). Several indepth 
chapters follow on developmental vascular biology, includ- 
ing topics such as expression ofcytoskeletal nd contractile 
proteins, structural organization, and extraceUular matrix 
linkages. Smooth muscle cell proliferation and its relevance 
to vascular disease is discussed in four separate chapters 
("Pharmacology of smooth muscle cell proliferation," 
"Smooth muscle cell proliferation i hypertension," "Reg- 
ulation of artetial smooth muscle growth," and "Relevance 
of smooth muscle replication and development to vascular 
disease") and in one overview ("Molecular controls of 
smooth muscle hypertrophy and hyperplasia"). Regulation 
of smooth muscle contractility, the main function of this 
cell type, is only discussed in one chapter that emphasizes 
gene expression of myosin heavy chains. This limited dis- 
cussion may be because the topic is so large that it would 
detract from the more central theme of vascular pathology 
or because there are many other well-written books on the 
subject (e.g., Biochemistry of smooth muscle contraction, 
edited by Michael B~r~ny, Academic Press, 1996). How- 
ever, an insightful review of the organization of the smooth 
muscle cytoskeleton and contractile apparatus i given in 
the chapter "Architecture of the smooth muscle cell" by 
J. Victor Small and Alison J. North. 
This book is a must for anyone involved in vascular or 
smooth muscle cell biology. 
Marilyn Cipolla, MS 
Oregon Health Sciences University 
Portland, Ore. 
Ethical issues in drug testing, approval, and pricing: 
The clot-dissolving drugs 
Baruch A. Brody, New York, 1995, Oxford University 
Press, 268 pages, $25. 
The book Ethical issues in drug testing, approval, and 
pricing: The clot-dissolving drugs by Baruch A. Brody is a 
268-page text that outlines the development, approval 
process, and marketing of the thrombolytic agents trep- 
toldnase, urokinase, recombinant tissue plasminogen acti- 
vator, and a variety of other experimental ctivators. The 
drugs are discussed primarily in the context of their use in 
the setting of acute myocardial infarction; little informa- 
tion exists on peripheral arterial and venous thrombosis. 
There is a strong bent on moral and ethical concerns 
throughout he text, both from the standpoint of the 
conduct of studies directed at gaining regulatory agency 
approval for clinical use of the agents, as well as with 
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respect to ethical conflict between clinical efficacy and eco- 
nomic cost. 
The book is divided into four sections. The first section 
deals with the development ofthrombolytic agents, begin- 
ning with the pioneering investigations of James Herrick, 
who in 1912 emphasized the association between acute 
coronary artery thrombosis and the clinical syndrome of 
myocardial infarction. Brody follows with an insightful 
account of the evolution of streptokinase, firstreported by 
Tiller and Garner in 1933. The remainder of the section 
outlines the various clinical trials of thrombolysis for coro- 
nary occlusion, including those organized by the NIH and 
those by the pharmaceutical companies. Links between 
investigators and the companies are discussed, naming in- 
dividuals, corporations, and their financial connections in 
the form of stock options. The latest rial of thrombolysis 
for myocardial infarction, the GUSTO trial, is outlined in 
the final portion of the section, discussing the possible 
relationship between Genentech's $55 million investment 
in the study, the unblinded study protocol, and the rather 
modest mortality differences between rt -PA (6.3%) and 
streptokinase (7.2% to 7.4%). 
The second, third, and fourth sections of the text 
describe ethical issues with regard to clinical trials, the 
approval process for new drugs, and the adoption of new 
agents. The use of placebos is discussed, as are conflicts of 
interest in the conduct of clinical trials. The history of the 
FDA approval procedure isoutlined, along with the ethical 
foundations of the process. Brody succinctly summarizes 
the clinical conflicts that arise as a result of discrepancies 
between cost and clinical efficacy; for example, whether the 
marginal difference in mortality rate between streptoldnase 
and rt-PA for acute myocardial infarction is worth the 
enormous cost differential. The text closes with a brief 
discussion of pricing of drugs, including an alarming table 
that illustrates a four-fold differential between the relative 
price of drugs from one country to another. 
In summary, the book provides a concise and easily 
understandable text on the development and ethical con- 
cerns of thrombolysis for acute myocardial infarction. Al- 
though similar issues occur with predictable consistency 
with regard to all new pharmaceutical agents, this book is 
not likely to be of interest o peripheral vascular surgeons 
other than those who are intimately involved with throm- 
bolytic research. 
Kenneth Ouriel, MD 
University of Rochester 
Rochester, N.Y. 
Venous disorders: A manual of  diagnosis and 
treatment 
G. Belcaro, A. N. Nicolaides, and M. Veller, London, 
1995, W. B. Saunders, 204 pages, $35. 
This is an attractive, liberally illustrative, albeit modest, 
monograph on venous disorders. Although the first au- 
thor, Dr. Belcaro, will not be immediately familiar to many 
American readers, his credentials, especially his training 
and continued active involvement at St. Mary's Hospital in 
London, seem more than adequate to his subject. The 
book itself has a soft cover but is nicely produced on 
high-quality stock with liberal use of illustrations, many in 
color. However, it is only 183 pages in length, and thus 
most subjects are treated in a rather cursory fashion. The 
authors write with a clear, declarative style, and there is a 
short bibliography at the end of each subject. However, 
the chapters themselves are not referenced, which will be a 
problem for most critical readers. 
My biggest concern with this inexpensive ($35) British 
book was trying to identify the readers for whom it was 
intended. A brief "preface" on the back cover states: "This 
practical manual aims to provide a concise account of these 
(venous) disorders ufficiently detailed to ensure a sound 
understanding of the mechanisms involved and to provide 
effective clinical care . . .  Most importantly, guidance is 
provided throughout on the most reliable and widely ac- 
cepted management options." I would contend that it 
achieves few of these objectives. 
The authors begin with a brief account of the anatomy 
and physiology of the venous and lymphatic systems, 
which is well done, and then move on to review the 
important venous disease syndromes that affect both the 
lower and upper extremities. However, each subject is 
covered in such brief fashion that important omissions are 
inevitable. For example, the use of venous duplex scanning 
to diagnose and manage venous thrombosis so short that 
it is impossible for the reader to correctly appreciate how to 
perform this study, what its limitations are, and how it has 
revolutionized our management of this widespread condi- 
tion. In the discussion on prophylaxis of venous thrombo- 
sis in general surgical and urologic patients, the role of 
intermittent pneumatic compression is limited to the state- 
ment "Intermittent pneumatic ompression is also effec- 
five." Low molecular weight heparins are barely men- 
tioned, and there is no discussion of their use in the 
outpatient management of acute deep venous thrombosis. 
By contrast, here are relatively detailed escriptions of the 
surgical correction of venous valvular insufficiency and the 
Klippel-Trenaunay s ndrome, which seem out of place in a 
monograph such as this. 
I ultimately concluded that this book would be of 
greatest use to medical students, vascular laboratory tech- 
nicians, and  general surgical residents who wanted a 
greater understanding of its subject matter. However, it is 
much too cursory for vascular residents and certainly inad- 
equate for practicing vascular surgeons. 
Richard Kempczinski, MD 
University of Cincinnati Medical Center 
Cincinnati, Ohio 
Endoluminal stenting 
Ulrich Sigwart, Philadelphia, 1996, W. B. Saunders, 
621 pages, $79. 
Endoluminal stenting is edited by one of the leaders in 
the field and gives an overview of stent applications 
throughout he body. This 1996 publication offers the 
most complete summary available of the science behind 
